Bruker Corporation (BRKR)

Currency in USD
53.41
+2.14(+4.17%)
Closed·
53.15-0.26(-0.49%)
·
BRKR is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
51.2053.47
52 wk Range
28.5365.30
Key Statistics
Prev. Close
51.27
Open
52.02
Day's Range
51.2-53.47
52 wk Range
28.53-65.3
Volume
2.11M
Average Volume (3m)
2.59M
1-Year Change
75.5176%
Book Value / Share
15.64
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BRKR Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
58.75
Upside
+10.00%
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year

Bruker Corporation News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Neutral

Analyst Ratings

8 Buy
4 Hold
1 Sell
Ratings:
13 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 58.75
(+10.00% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
JPMorgan
Buy42.00-21.36%38.00MaintainAug 05, 2026
Stifel
Hold50.00-6.38%45.00MaintainAug 05, 2026
Jefferies
Buy62.00+16.08%53.00MaintainAug 04, 2026
Citi
Hold60.00+12.34%-New CoverageJul 30, 2026
Guggenheim
Buy70.00+31.06%-MaintainJul 13, 2026

Bruker Corporation Earnings Call Summary for Q2/2026

  • Bruker Q2 2026 EPS of $0.49 beat estimates by 28%, but revenue of $838.5M missed forecasts; shares plunged 16.82% to $53.50 on soft growth outlook.
  • Non-GAAP operating margin expanded 510 bps to 14.1% on cost cuts and tariff benefits; organic revenue growth returned at modest 2.8% after prior weakness.
  • Company maintained full-year EPS guidance of $2.10-$2.15 but cut FX tailwind assumption; organic revenue growth outlook unchanged at 1%-2% for 2026.
  • Q3 guidance disappoints with flat-to-slightly positive organic growth and sequential margin pressure; Q4 expected stronger at $1.02B-$1.04B revenue.
  • Biopharma bookings surged 20%+ and semiconductor metrology showed strong momentum, offsetting continued weakness in U.S. academic and government spending.
Last Updated: 08/04/2026, 10:48 PM
Read Full Transcript

Earnings

Latest Release
Aug 05, 2026
EPS / Forecast
0.49 / 0.38
Revenue / Forecast
838.5M / 853.39M
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS -0.70%
Dividend Yield
0.39%
Industry Median 1.50%
Annualized payout
0.20
Paid quarterly
5-Years Growth
-8.97%
Growth Streak

BRKR Income Statement

Compare BRKR to Peers and Sector

Metrics to compare
BRKR
Peers
Sector
Relationship
P/E Ratio
−76.1x−7.0x−0.4x
PEG Ratio
0.320.010.00
Price/Book
3.4x1.1x2.6x
Price / LTM Sales
2.3x2.3x3.0x
Upside (Analyst Target)
12.3%7.5%48.7%
Fair Value Upside
Unlock10.5%5.6%Unlock

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools; innovative nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) products; solutions for in-vivo processes and drug discovery; aftermarket solutions; solutions for lab automation and digitalization; mass spectrometry solution and test kits, DNA test strips, and fluorescence-based PCR technologies; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; services for transcriptional profiling and multiomic analysis; superconducting materials, such as metallic low temperature superconductors; multifilament round and rectangular LTS wires in both monolithic and wire-in-channel formats; designs and manufactures Cuponal; metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation was founded in 1960 and is headquartered in Billerica, Massachusetts.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
67.98M44.62%3.63B
Other Institutional Investors
80.39M52.76%4.29B
Public Companies & Retail Investors
3.99M2.62%213.19M
Total
152.36M100.00%8.14B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
FMR LLC12.16%18,529,064989,637
Orbis Investment Management Limited11.76%17,911,754956,667

People Also Watch

226.73
CBRS
+7.30%
133.11
SPCX
+15.83%
135.630
AAOI
+9.19%
13.590
RDW
+14.88%
8.91
POET
+4.45%

FAQ

What Is the Bruker (BRKR) Stock Price Today?

The Bruker stock price today is 53.41 USD.

What Stock Exchange Does Bruker Trade On?

Bruker is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Bruker?

The stock symbol for Bruker is "BRKR."

Does Bruker Pay Dividends? What’s The Current Dividend Yield?

The Bruker dividend yield is 0.37%.

What Is the Bruker Market Cap?

As of today, Bruker market cap is 7.81B USD.

What Is Bruker's Earnings Per Share (TTM)?

The Bruker EPS (TTM) is -0.70.

When Is the Next Bruker Earnings Date?

Bruker will release its next earnings report on Oct 29, 2026.

From a Technical Analysis Perspective, Is BRKR a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Bruker Stock Split?

Bruker has split 0 times.

How Many Employees Does Bruker Have?

Bruker has 11085 employees.

What is the current trading status of Bruker (BRKR)?

As of Aug 08, 2026, Bruker (BRKR) is trading at a price of 53.41 USD, with a previous close of 51.27 USD. The stock has fluctuated within a day range of 51.20 USD to 53.47 USD, while its 52-week range spans from 28.53 USD to 65.30 USD.

What Is Bruker (BRKR) Price Target According to Analysts?

The average 12-month price target for Bruker is 58.75 USD, with a high estimate of 70 USD and a low estimate of 40 USD. 8 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an +10.00% Upside potential.

What Is the BRKR Premarket Price?

BRKR's last pre-market stock price is 51.17 USD. The pre-market share volume is 560.00, and the stock has decreased by -0.10, or -0.20%.

What Is the BRKR After Hours Price?

BRKR's last after hours stock price is 53.15 USD, the stock has decreased by -0.26, or -0.49%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.